Plain-English translation of NCT06320158 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are trying to understand sarcopenic obesity — a condition where older adults have both excess fat and weak muscles at the same time. This study will collect blood samples and muscle ultrasound scans from older people to identify the cellular and molecular changes that cause this condition, so doctors can eventually develop better treatments tailored to individual patients.
Sarcopenic obesity is becoming more common in older people and increases the risk of disability and poor quality of life, but doctors don't fully understand what causes it. This research aims to identify early warning signs so that at-risk individuals can be treated before the condition becomes severe.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will complete questionnaires and scales about your health, have your blood drawn by venous sampling, and undergo a muscle ultrasound scan. If you are a healthy participant, you will also complete a short physical performance battery test. The study is observational, meaning researchers are collecting information and samples to study — not testing a new medication or treatment.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Italy
Enrollment target
~1,108 participants
Started
May 2023
Primary completion
November 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
65 Years – 99 Years
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Patrizia Rovere Querini, PhD, MD
IRCCS San Raffaele
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.